In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Effective Sponsor-CRO Collaboration
In this PharmaVOICE article, read commentary from Dr. Phil Birch on effectivesponsor-CRO collaboration.
-
ICON Recognised for Excellence in Vaccine Development
Coverage of ICON's recent award at the ViE Awards. these awards honor individuals and organisations that continually set standards of excellence and have made outstanding achievements in the vaccine industry.
-
Predatory Journals Are Back in the Firing Line
Learn how to spot apredatory journalwith these tips from PubsHub.
-
Overcoming Four Challenges to Successful Rare Disease Drug Development
ICON contributed to this article in Pharmafocus relating to overcoming four challenges to greatly improve the chances for a successful rare or “orphan” drug trial.
-
Why a Patient's Experience with a Drug Matters
Patient reported outcomesare often the primary endpoints in FDA approved pain drugs. Andy Smith shares his insights inMednous.
-
PRO Instruments to Improve Endpoints for Antibacterial Drug Trials
Brittany Erana contributes to this article that features theFDA's selection ofICON to validate PRO instruments used to access clinical endpoints in antibacterial drug trials.
-
Cell and Gene Therapies: On Course for Commercial Success?
Rebecca Walker contributes to this PMLiVE article oncell and gene therapies.
-
Market Access 2017: A European Perspective
Ramita Tandon was interviewed in “Market Access 2017: A European Perspective” in the Pharmaceutical Executive. The article discusses how UK and European regulators’ market access plans for 2017 will affect the industry.
-
Medtech Needs Clinical Registries for Pre- and Postmarket Data
Vicki Anastasi share her insights onclinical registries and generating pre- and postmarket datain this interiew in Medical Design and Outsourcing.
-
Precision Medicine and Data Science
In this article Peter Schueler outlines the future ofdrug development and the central role that precision medicinewill play in global healthcare.
